Adenocarcinoma of the Rectum Completed Phase 1 / 2 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00551421Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerTreatment